Dossier · CTSH · Dormant
CTSH · Cognizant Technology Solutions Corporation · Stock research
Last analysed ·
Against its published line
The red mark is the published kill line. The dot is where the name closed on 7 August 2026. Distance is drawn on a square-root scale, so the first two points of cushion take half the track and a name sitting on its line is legible; past 8% a name reads simply as well clear. A trigger written on weekly closes is graded on weekly closes, so a name trading through such a line mid-week reads as pending, not hit.
Current thesis
Legacy IT-services franchise being re-underwritten as an enterprise-AI deployment partner; the leg still works — $61.87 on 2026-08-21, up 18.0% over three months — but the sell-side revision wave ended 2026-07-30, price now sits ~3% under the $63.94 29-analyst mean target with RSI 75.3, and nothing resolves until the ~2026-10-28 Q3 print.
Kill line
A weekly close below $56 gives back the entire August extension and returns price beneath the 2026-08-07 close of $57.67; secondarily, the ~2026-10-28 Q3 print landing revenue under the guided $5.600B floor, or a second FY26 revenue-guide cut.
Pick status
Open commitment scored if the kill line above fires How this is scored →Latest analysis and events for CTSH —
As of 22 August 2026, the latest FrontierPicks analysis for Cognizant Technology Solutions Corporation (CTSH): Legacy IT-services franchise being re-underwritten as an enterprise-AI deployment partner; the leg still works — $61.87 on 2026-08-21, up 18.0% over three months — but the sell-side revision wave ended 2026-07-30, price now sits ~3% under the $63.94 29-analyst mean target with RSI 75.3, and nothing resolves until the ~2026-10-28 Q3 print.
Kill line: A weekly close below $56 gives back the entire August extension and returns price beneath the 2026-08-07 close of $57.67; secondarily, the ~2026-10-28 Q3 print landing revenue under the guided $5.600B floor, or a second FY26 revenue-guide cut.
Current Thesis
The leg on offer is unchanged in kind and further along in price: a legacy IT-services franchise, priced for AI-driven revenue deflation, being re-underwritten as an enterprise-AI deployment partner. The 2026-07-29 Q2 print remains the pivot document — adjusted operating margin 16.0% (+40bps YoY), FY26 adjusted EPS guidance lifted to $5.70–$5.82 from $5.63–$5.77, $1.153B of stock retired in the quarter — against an FY26 revenue band cut to $22.040–$22.350B from $22.110–$22.640B versus $22.290B consensus. What has changed since early August is the flow, not the fundamentals: price closed at $61.87 on 2026-08-21 after $57.67 on 2026-08-07, up 18.0% over three months, while the sell-side revision wave that powered the move ended on 2026-07-30 and has produced only maintains since.
The narrative is maturing. The dating: the target-revision cluster (Wells Fargo $67, Citigroup $60, TD Cowen $54, Morgan Stanley $51, Susquehanna $82) landed 2026-07-30 and nothing has been raised above it in the three weeks since — Deal headlines have narrowed from the 2026-07-27 Anthropic Global Premier Partner announcement to single-client items such as the 2026-08-17 Benchling implementation for Kyowa Kirin at its Tokyo and Fuji Research Parks. The average target across 29 analysts stands at $63.94 (stockanalysis.com, 2026-08-22), roughly 3% above the last close. The name is well known, still working, and drawing a thinner stream of fresh headlines than it did in late July.
Bullish and bearish views on Cognizant Technology Solutions Corporation
The model's bull view on Cognizant Technology Solutions Corporation (CTSH), in brief: Q2 2026 (2026-07-29): revenue $5.481B, +4.5% YoY and +4.1% constant currency; adjusted operating margin 16.0% (+40bps YoY), GAAP 15.9%; adjusted EPS $1.37, GAAP $1.36. The bear view: The revenue guide moved the other way on the same call. Both cases follow in full.
Bull Case
- Q2 2026 (2026-07-29): revenue $5.481B, +4.5% YoY and +4.1% constant currency; adjusted operating margin 16.0% (+40bps YoY), GAAP 15.9%; adjusted EPS $1.37, GAAP $1.36.
- FY26 adjusted EPS guidance raised to $5.70–$5.82 from $5.63–$5.77 against an unchanged 16.0%–16.2% adjusted margin band — the raise comes from margin delivery and share count, both disclosed line items.
- Financial Services $1.733B, +12.0% YoY (+11.7% cc) in Q2 — the largest segment compounding at roughly three times the company rate.
- Trailing-twelve-month bookings $29.1B, +5% YoY, book-to-bill ~1.3x, with seven $100M+ TCV deals signed in Q2.
- Capital return: $1.153B repurchased in Q2 (22.5M shares), $1.6B in 1H 2026; $0.33 quarterly dividend payable 2026-08-25.
- The AI partnership stack is dated and specific: 2026-07-27 expanded Anthropic partnership with Global Premier Partner status in the Claude Partner Network, a Google Cloud Gemini Enterprise expansion, OpenAI GPT-5.5 integration for Cybersecurity services, and the Neuro AI Trust governance platform.
- Logo flow has continued at smaller scale: the 2026-07-27 five-year Andover Companies policy-administration agreement, then the 2026-08-17 Benchling/Kyowa Kirin work in Japan.
- No sell-side capitulation into the advance: Wells Fargo maintained Buy with a $67 target on 2026-08-12, two weeks after the print and above the prevailing price.
Bear Case
- The revenue guide moved the other way on the same call. FY26 cut to $22.040–$22.350B versus $22.290B consensus; Q3 guided to $5.600–$5.680B versus $5.703B consensus, putting the top of the guide below the street number.
- The headline was a double miss: adjusted EPS $1.37 versus $1.38 estimate, revenue $5.481B versus $5.482B estimate.
- Q2 in-quarter bookings fell 6% YoY. The +5% figure investors quote is trailing-twelve-month.
- Growth is one segment deep. Health Sciences $1.572B (+1.4% YoY), Products & Resources $1.322B (+1.2%), Communications/Media/Technology $854M (+1.5%) in Q2. Excluding Financial Services, the franchise printed close to flat.
- Price has walked through most of the published target distribution. The 2026-08-21 close of $61.87 sits above five of the nine dated targets on record since 2026-07-24 — Citigroup $60, JP Morgan $55, TD Cowen $54, Morgan Stanley $51, RBC $47 — and below four: Susquehanna $82, Wells Fargo $67, Guggenheim $65, Mizuho $64. The 29-analyst rating split is 16 Hold against 13 Buy-equivalent, zero Sell.
- Nine weeks of empty calendar. No company event between 2026-08-25 and the estimated late-October Q3 print tests the $5.600B revenue floor or the margin band.
Setup & Price Structure
- Reference close 2026-08-21: $61.87. 27.3% below the $85.16 52-week high; up 18.0% over three months. The derating that created the setup is only partly retraced.
- Momentum has not reset. RSI(14) reads 75.3 as of 2026-08-21, against 80.3 on 2026-08-07 — two-plus weeks above 70 while price advanced from $57.67 to $61.87. The overbought condition worked off through time and higher prices rather than through a pullback.
- Crowding observables, stated flat: price roughly 3% under the $63.94 mean target; five of nine published targets now sit beneath the market; two Form 4 sales dated 2026-08-03 at $55.764 and $57.05; no earnings date inside 30 days, so no event bid and no scheduled expectations reset.
- Structure: the whole advance is post-2026-07-29. The low-$50s zone price occupied ahead of the print is the floor of the move; the 2026-08-07 close of $57.67 marks the shelf the August extension was built on. A weekly close below $56 would put price beneath both and leave the guide raise unpaid for.
Catalyst Calendar (next 30 days)
- ~2026-09-24 (est.) — Accenture fiscal Q4 results, historically late September. Third-party read on enterprise discretionary IT spend and AI-services bookings; the closest dated demand signal before Cognizant's own print.
- ~2026-10-28 (est.) — Q3 2026 earnings, outside the 30-day window. The company's investor-events page listed no scheduled event as of 2026-08-22.
Elapsed catalysts
- 2026-08-25 — $0.33 quarterly dividend payable; record date 2026-08-18 has passed. Mechanical, tests nothing in the guidance. (passed 1d ago)
What Would Change Our Mind
The August extension is the segment of the move with no new information underneath it — the last incremental target raise is dated 2026-07-30, and the price added roughly four dollars after that on deal headlines of ordinary size. If that extension unwinds, the market has repriced the guide raise as fully paid: a weekly close below $56 returns price beneath the 2026-08-07 close of $57.67 and back toward the pre-print zone, which would break the structure the whole re-rating rests on. Secondarily, the estimated 2026-10-28 Q3 print landing revenue under the guided $5.600B floor, or a second consecutive FY26 revenue-band cut, would confirm that EPS is being manufactured while the top line slides.
The reverse would also move the read: Q3 revenue at or above $5.680B with the FY26 band held or lifted, in-quarter bookings back positive, and growth broadening beyond Financial Services would turn this from a margin-and-buyback story into a demand story and make the $67–$82 high-side targets the relevant reference points. A shift to saturated would be dated by mainstream coverage framing a name 27% below its 52-week high as an AI winner while no target moves above $67 through September.
Correlation Notes
- IT-services complex: trades with Accenture, Infosys, Wipro and EPAM on the same question — whether agentic AI compresses billable headcount faster than it creates deployment work. Accenture's fiscal Q4, historically late September, prices that debate for the group before Cognizant reports.
- India delivery and FX: 356,700 employees at Q2 2026 with a large India base. Rupee moves and US visa policy feed the 16.0%–16.2% adjusted margin band directly, independent of demand.
- Index beta is not the driver here. The Nasdaq 100 entered correction on 2026-07-28; Cognizant advanced 18.0% over the trailing three months through 2026-08-21, so the move has been name-specific rather than tape-driven.
- Two-sided AI headline risk: each frontier-model capability announcement is simultaneously a partnership input (Anthropic, Google Cloud, OpenAI, all dated 2026-07-27) and a services-deflation input. The same news can be read either way, which is why the multiple has been unstable.
Notes
- Calendar fiscal year: Q3 reports late October, Q4/FY in early February. Q2 2026 was reported 2026-07-29.
- Company guides both reported and constant-currency revenue; Q2 2026 printed +4.5% reported against +4.1% cc.
- Buyback is a material EPS driver — $1.6B repurchased in 1H 2026. Read organic revenue growth separately from EPS growth.
- 356,700 employees at Q2 2026 with a large India delivery base; rupee moves and US visa policy feed the adjusted margin band directly.
- Dividend is declared quarterly alongside earnings; the current rate is $0.33 per share.
- Senior officers sell under pre-arranged Rule 10b5-1 plans adopted in May 2026, so individual Form 4s are scheduled rather than discretionary.
Related · shared themes
MRCY
Mercury Systems Inc
Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.
OKTA
Okta, Inc.
Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme accelerating, this leg maturing; open risk is paying up for a stretched 52-week-high tape.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
ARCB
ArcBest Corporation
The twice-tested $135.76/$135.89 shelf lost on the 2026-08-24 close of $134.45, a 4.2% drop taken with the whole transport complex after Trump's 50% Canada auto/truck/parts/steel tariff post. No issuer catalyst until Q3 results ~2026-10-28; the 2026-08-28 weekly close is the first gradeable test of whether the break holds.
See also · stocks to watch